3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
4
Multiple Myeloma
2
Vaccinia
1
Transplant-Related Hematologic Malignancy
1
Recurrence
1
Prostatic Neoplasms
1
Oligodendroglioma
1
Neoplasms
1
Medulloblastoma
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Kidney Neoplasms
1
Hodgkin Disease
1
Glioma
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Hepatocellular
1
Brain Neoplasms
1
Interventions
venetoclax
30
Rituximab
26
ibrutinib
22
acalabrutinib
22
Cyclophosphamide
22
Specimen Handling
20
obinutuzumab
17
Biopsy
15
fludarabine
13
zanubrutinib
11
pirtobrutinib
10
fludarabine phosphate
10
Magnetic Resonance Spectroscopy
9
Bendamustine Hydrochloride
9
Lenalidomide
7
CT-P10
7
idelalisib
6
Whole-Body Irradiation
6
Mycophenolic Acid
6
ARQ531
6
Cyclosporine
5
Vincristine
4
Sirolimus
4
Prednisone
4
Peripheral Blood Stem Cell Transplantation
4
Doxorubicin
4
Blood Component Removal
4
pembrolizumab
3
Tacrolimus
3
Stem Cell Transplantation
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Lymphocytic, Chronic, B-Cell
×
Granulocyte-Macrophage Colony-Stimulating Factor
×
90 days
×
Clear all
No trials found.